Additive Effects of .BETA.-Blockers on Renin-Angiotensin System Inhibitors for Patients After Acute Myocardial Infarction Treated With Primary Coronary Revascularization-Reference-Cited by-同舟云学术

Additive Effects of .BETA.-Blockers on Renin-Angiotensin System Inhibitors for Patients After Acute Myocardial Infarction Treated With Primary Coronary Revascularization

Published:2011 Issue:8 Volume:75 Page:1982-1991
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Konishi Masanori¹,Haraguchi Go¹,Yoshikawa Shunji¹,Kimura Shigeki¹,Inagaki Hiroshi¹,Isobe Mitsuaki¹

Affiliation:

1. Department of Cardiovascular Medicine, Tokyo Medical and Dental University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/75/8/75_CJ-10-1241/_pdf

Reference29 articles.

1. 1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004; 110: 588-636.

2. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)

3. 3. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial: The SAVE Investigators. N Engl J Med 1992; 327: 669-677.

4. 4. Scheen AJ, Krzesinski JM. ONTARGET: Similar protection of telmisartan and ramipril and lack of benefit of combined therapy in patients at high risk for vascular events. Rev Med Liege 2008; 63: 213-219 (in French).

5. EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTION

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond β-Blockade: ACE Inhibitors Reduce Non-Cardiac Mortality in High Killip Grade AMI Patients;Journal of Cardiovascular Pharmacology and Therapeutics;2024-07-21

2. Clinical impact of beta-blockers at discharge on long-term clinical outcomes in patients with non-reduced ejection fraction after acute myocardial infarction;Journal of Cardiology;2023-01

3. New Formula to Predict Heart Rate at Anaerobic Threshold That Considers the Effects of β-Blockers in Patients With Myocardial Infarction;Journal of Cardiopulmonary Rehabilitation and Prevention;2021-04-20

4. Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization;Scientific Reports;2020-09-16

5. β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study;BMC Cardiovascular Disorders;2020-04-09